13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001590144
Total reported value
$37.0M
$37.0M
17 檔
29.3%
At the close of Q1 2026, Pura Vida Investments, LLC disclosed equity holdings valued at approximately $37.0M, spread across 17 reported holdings.
During Q1 2026, Pura Vida Investments, LLC performed routine portfolio adjustments (0 new buys, 3 additions, 1 trims, and 1 full exits), keeping overall allocation balanced.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IMDX | Insight Molecular Diagnostic | Stock-Other | 20.88% | -13.15% | — | |
| 2 | BBNX | Beta Bionics Inc | Stock-Other | 18.94% | -7.03% | — | |
| 3 | ✓ | Establishment Labs Holdings In | Stock-Other | 17.17% | -6.73% | — | |
| 4 | CAI | Caris Life Sciences Inc | Stock-Other | 10.81% | -9.58% | — | |
| 5 | NSPR | Inspiremd Inc | Stock-Other | 4.94% | -4.09% | — | |
| 6 | NTRA | Natera Inc | Stock-Healthcare | 3.36% | -2.26% | — | |
| 7 | NVDA | Nvidia CORP | Stock-Tech | 2.93% | -1.69% | +7.30% | |
| 8 | JPM | Jpmorgan Chase & Co | Stock-Financials | 2.67% | -1.48% | — | |
| 9 | MSFT | Microsoft CORP | Stock-Tech | 2.46% | -1.45% | -17.50% | |
| 10 | MGX | Metagenomi Therapeutics Inc | Stock-Other | 2.38% | -1.53% | — | |
| 11 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 2.29% | -1.14% | — | |
| 12 | OM | Outset Medical Inc | Stock-Other | 2.15% | -1.18% | +1566.66% | |
| 13 | ADI | Analog Devices Inc | Stock-Tech | 2.14% | -1.07% | — | |
| 14 | AAPL | Apple Inc | Stock-Tech | 1.99% | -1.08% | — | |
| 15 | ASML | ASML Holding N.V. | Stock-Tech | 1.69% | -0.67% | — | |
| 16 | LIN | Linde plc | Stock-Materials | 1.67% | -0.97% | — | |
| 17 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 1.54% | -0.83% | +10.00% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Establishment Labs Holdings In | +4.9% | — | Unchanged |
| 2 | NSPR | Inspiremd Inc | +1.9% | — | Unchanged |
| 3 | CAI | Caris Life Sciences Inc | +1.7% | — | Unchanged |
| 4 | NVDA | Nvidia CORP | +1.3% | +7.30% | Add |
| 5 | NTRA | Natera Inc | +1.2% | — | Unchanged |
| 6 | ADI | Analog Devices Inc | +1.1% | — | Unchanged |
| 7 | JPM | Jpmorgan Chase & Co | +1% | — | Unchanged |
| 8 | OM | Outset Medical Inc | +1% | +1566.66% | Add |
| 9 | ASML | ASML Holding N.V. | +0.9% | — | Unchanged |
| 10 | GOOG | Alphabet Inc-cl C | +0.9% | — | Unchanged |
| 11 | LIN | Linde plc | +0.9% | — | Unchanged |
| 12 | AAPL | Apple Inc | +0.8% | — | Unchanged |
| 13 | MGX | Metagenomi Therapeutics Inc | +0.8% | — | Unchanged |
| 14 | AMZN | Amazon.com Inc | +0.7% | +10.00% | Add |
| 15 | MSFT | Microsoft CORP | +0.3% | -17.50% | Trim |
| 16 | IMDX | Insight Molecular Diagnostic | -5.7% | — | Unchanged |
| 17 | BBNX | Beta Bionics Inc | -13.1% | — | Unchanged |
| 18 | DHR | Danaher CORP | — | EXIT | Sold out |
According to official SEC Form 13F filings, Pura Vida Investments, LLC reported a total U.S. public equity portfolio value of $37.0M across 17 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including IMDX, BBNX, ESTABLISHMENT LABS HOLDINGS IN) accounted for 29.3% of total reported equity market value during Q1 2026.
Top Position Liquidated / Trimmed
DHR
前期市值: $206.0K
During Q1 2026, Pura Vida Investments, LLC's top holdings by market value included IMDX (20.9%)、BBNX (18.9%)、ESTABLISHMENT LABS HOLDINGS IN (17.2%). The largest single position, IMDX, represented 20.9% of total portfolio value.
In Q1 2026, Pura Vida Investments, LLC made 5 total portfolio adjustments, initiating 0 new buys, adding to 3 positions, trimming 1 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.